Stocks INGM Financial statements
Financial statementsIngram Micro Holding Corp financial statements
Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Ingram Micro Holding Corp files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Revenue | 50,824 | 48,040 | 47,984 | 52,556 |
| Cost of revenue | 47,131 | 44,493 | 44,539 | 49,052 |
| Gross profit | 3,693 | 3,547 | 3,445 | 3,504 |
| Selling, general and administrative | 2,716 | 2,584 | 2,589 | 2,612 |
| Operating expenses | 444 | 2,603 | 2,627 | 2,627 |
| Operating income | 3,249 | 944 | 818 | 877 |
| Interest expense | 320 | 380 | 338 | 303 |
| Interest income | 22.9 | 35 | 45.3 | 45.7 |
| Other non-operating income | -434 | -422 | -372 | -346 |
| Pre-tax income | 2,815 | 523 | 446 | 531 |
| Income tax | 420 | 170 | 182 | 203 |
| Net income | 2,394 | 353 | 264 | 328 |
| EBITDA | 3,446 | 1,128 | 1,007 | 1,074 |
| EPS, basic | 10.77 | 1.59 | 1.18 | 1.40 |
| EPS, diluted | 10.77 | 1.59 | 1.18 | 1.39 |
| Shares, basic (weighted) | 222 | 222 | 225 | 235 |
| Shares, diluted (weighted) | 222 | 222 | 225 | 235 |
| Dividend per share | 0.31 |
Balance sheet
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Cash and equivalents | 1,320 | 948 | 918 | 1,865 |
| Receivables | 8,989 | 9,448 | 10,547 | |
| Inventory | 4,660 | 4,699 | 4,970 | |
| Other current assets | 757 | 735 | 859 | |
| Total current assets | 15,354 | 15,801 | 18,241 | |
| Property, plant and equipment | 453 | 483 | 532 | |
| Lease right-of-use assets | 431 | 413 | 403 | |
| Goodwill | 845 | 852 | 834 | 855 |
| Intangible assets | 880 | 773 | 712 | |
| Other non-current assets | 450 | 477 | 502 | |
| Total assets | 18,420 | 18,780 | 21,244 | |
| Accounts payable | 9,230 | 10,006 | 11,963 | |
| Accrued liabilities | 1,061 | 1,022 | 1,164 | |
| Short-term debt | 266 | 185 | 450 | |
| Total current liabilities | 10,663 | 11,307 | 13,681 | |
| Long-term debt | 3,658 | 3,168 | 2,750 | |
| Lease liabilities | 366 | 369 | 355 | |
| Other non-current liabilities | 227 | 202 | 210 | |
| Total liabilities | 14,914 | 15,046 | 16,996 | |
| Total debt | 3,924 | 3,353 | 3,199 | |
| Paid-in capital | 2,656 | 2,904 | 2,922 | |
| Retained earnings | 1,080 | 1,337 | 1,587 | |
| Treasury stock | 0 | |||
| Other comprehensive income | -231 | -510 | -263 | |
| Shareholders' equity | 3,058 | 3,506 | 3,734 | 4,248 |
| Total equity | 3,058 | 3,506 | 3,734 | 4,248 |
| Total liabilities and equity | 18,420 | 18,780 | 21,244 | |
| Shares outstanding | 235 | 235 |
Cash flow statement
| FY2022 | FY2024 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Net income | 2,394 | 353 | 264 | 328 |
| Depreciation and amortization | 197 | 184 | 189 | 197 |
| Stock-based compensation | 0 | 0 | 34.1 | 21.1 |
| Deferred income tax | 17.3 | -58.5 | -13.3 | -28 |
| Change in receivables | -591 | -300 | -1,061 | -1,106 |
| Change in inventory | -210 | 772 | -226 | -88.2 |
| Change in payables | 350 | -738 | 976 | 1,709 |
| Cash from operations | -361 | 58.8 | 334 | 916 |
| Capital expenditures | -136 | -202 | -143 | -131 |
| Cash from investing | 3,029 | -17.7 | 106 | 268 |
| Debt repaid | -518 | -560 | -483 | -125 |
| Dividends paid | -1,754 | -10.5 | -6.17 | -78.4 |
| Cash from financing | -2,465 | -478 | -391 | -306 |
| Exchange rate effect | -134 | 65.2 | -78.2 | 68.8 |
| Net change in cash | 92.3 | -372 | -30.1 | 946 |
| Free cash flow | -497 | -143 | 191 | 785 |
| Interest paid | 320 | 379 | 336 | 301 |
| Income taxes paid | 443 | 272 | 252 | 182 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 6.6% | Gross profit / revenue. |
| Operating margin | 1.8% | Operating income / revenue. |
| EBITDA margin | 2.1% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 1.2% | Pre-tax income / revenue. |
| Net margin | 0.8% | Net income / revenue. |
| FCF margin | -0.4% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | -0.2% | Cash from operations / revenue. |
| Effective tax rate | 35.6% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 10.1% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 2.0% | Net income / average total assets. |
| Return on invested capital (ROIC) | 8.8% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 4.8% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 0.1% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.2% | Capital expenditures / revenue. |
| D&A / revenue | 0.4% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 9.5% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 1.1% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 1.7% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -1.7% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | 7.2% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | -35.4% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 6.6% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -32.2% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | 24.1% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -48.5% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | 17.8% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | -49.5% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 174.4% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow growth, 1y | 310.9% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | 13.8% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 11.6% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 13.1% | Total assets vs the same period a year earlier. Only from a positive base. |
| Share count change, 1y | 4.7% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 1.9% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.31x | Current assets / current liabilities. |
| Quick ratio | 0.81x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.06x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.89x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 17.6% | Total debt / total assets. |
| Liabilities / assets | 80.1% | Total liabilities / total assets. |
| Net debt | $2.99B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 2.51x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 3.29x | Operating income / interest expense. |
| Working capital | $4.37B | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 7.0% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $2.77B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 2.60x | Revenue / average total assets. |
| Fixed asset turnover | 106x | Revenue / average property, plant and equipment. |
| Inventory turnover | 8.68x | Cost of revenue / average inventory. |
| Days inventory | 42 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 5.24x | Revenue / average receivables. |
| Days sales outstanding | 70 days | 365 x average receivables / revenue. |
| Days payables | 82 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 29 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | -53.8% | Free cash flow / net income, when net income is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $1.85 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $241.03 | Revenue / diluted weighted shares. |
| FCF per share | -$1.00 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | -$0.42 | Cash from operations / diluted weighted shares. |
| Book value per share | $18.18 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $11.75 | Tangible book value / shares outstanding. |
| Cash per share | $3.44 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 17.6% | Dividends paid / net income, when net income is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $6.22B | Share price x shares outstanding. |
| Enterprise value | $9.21B | Market cap + total debt - cash - short-term investments. |
| P/E | 14.5x | Market cap / net income. Only when net income is positive. |
| P/S | 0.11x | Market cap / revenue. |
| P/B | 1.45x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 2.25x | Market cap / tangible book value, when positive. |
| EV/Sales | 0.16x | Enterprise value / revenue. |
| EV/EBIT | 9.28x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 7.74x | Enterprise value / EBITDA, when both are positive. |
| FCF yield | -3.7% | Free cash flow / market cap. |
| Earnings yield | 6.9% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 1.2% | Dividends paid over the period / market cap. |
| Shareholder yield | 1.2% | (Dividends paid + share buybacks) / market cap. |
What was Ingram Micro Holding Corp's revenue in fiscal 2025?
Ingram Micro Holding Corp reported revenue of $52.56B for fiscal 2025, 9.5% higher than the year before.
Was Ingram Micro Holding Corp profitable in fiscal 2025?
Yes. Net income was $327.9M, a net margin of 0.6%.
How much free cash flow did Ingram Micro Holding Corp generate in fiscal 2025?
Cash from operations of $916.1M minus capital expenditures of $130.8M left free cash flow of $785.4M.